Luigi Naldi
Advanced in Erythema Multiforme

Luigi Naldi

Bergamo, IT 
Advanced in Erythema Multiforme
Bergamo, IT 
OverviewLocationsClinical Research

Overview

Luigi Naldi practices in Bergamo, Italy. Mr. Naldi is rated as an Advanced expert by MediFind in the treatment of Erythema Multiforme. His top areas of expertise are Psoriasis, Plaque Psoriasis, Atopic Dermatitis, and Prurigo Nodularis.

His clinical research consists of co-authoring 315 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Erythema Multiforme.

Gender
Male

Locations

Bergamo, Italy
Other Locations
Vicenza, Italy
Florence, 50139, Italy
Benevento, Italy
San Bortolo, Italy
Papa Giovanni Xxiii, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7
Enrollment Status: Completed
Publish Date: August 11, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

315 Total Publications

Association of comorbidities and drug intake with generalized chronic pruritus: A multicenter case-control study in Switzerland and Italy.
Association of comorbidities and drug intake with generalized chronic pruritus: A multicenter case-control study in Switzerland and Italy.
Journal: JAAD international
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Naldi's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 53 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile